HFA Premium Access

First-in-man trial of Beta-3-adrenoceptor agonist in chronic heart failure - effect on diastolic function

Presentation

About the speaker

Doctor Anna Axelsson Raja

Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

13 more presentations in this session

Morbidity, mortality, and cost impact of stage b and stage c heart failure: comparative analysis to underline the clinical and economic need for heart failure prevention strategy.

Speaker: Doctor S. James (Dublin, IE)

Thumbnail

Effects of 5 years treatment with nebivolol, carvedilol and bisoprolol in heart failure patients

Speaker: Doctor G. Marazzi (Rome, IT)

Thumbnail

MTP-131, a cardiolipin-targeting peptide, improves mitochondrial activity in the failing human heart

Speaker: Doctor B. Stauffer (Aurora, US)

Thumbnail

Is the cohort of paradigm-hf representative of the real world population of patients with systolic heart failure?

Speaker: Doctor G. Rocha Rodrigues (Lisboa, PT)

Thumbnail

Evidence-based medications in multi-ethnic Asian patients with heart failure are associated with better outcomes in spite of lower doses

Speaker: Doctor T. Teng (Singapore, SG)

Thumbnail

Access the full session

Rapid Fire 3 - Chronic heart failure management

Speakers: Doctor A. Axelsson Raja, Doctor S. James, Doctor G. Marazzi, Doctor B. Stauffer, Doctor G. Rocha Rodrigues...
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk